4
Changes in Ownership
Raphael Pharmaceutical Inc. Filed Acc 0001213900-25-023367
Options or other derivatives
- Director acquired 200,000 shares (grant or award)
- Director disposed of 202,000 shares (code E)
From the SEC's structured data for this filing
Trades in this filing
Eliya Yehuda · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-10 | Grant or award : show line 1 in the form Warrant to purchase Common Stock | +200,000 | 200,000 | D |
| 2022-05-12 | Other disposition : show line 2 in the form Warrant to purchase Common Stock | −202,000 | 0 | D |
Loading xslF345X05/ownership.xml…